Public Health Webinar Series on Blood Disorders

Public Health Webinar Series on Blood Disorders: Bringing Science Into Practice

CDC’s Division of Blood Disorders (DBD) is proud to offer its Public Health Webinar Series on Blood Disorders. The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. We invite you to join us in this series.

Archives for 2020

Holger J. Schünemann, MD, MSc, PhD, FRCPC

March 5, 2020

Holger J. Schünemann, MD, MSc, PhD, FRCPC
Professor of Clinical Epidemiology and of Medicine
Departments of Health Research Methods, Evidence, and Impact and of Medicine
Director, Cochrane Canada and McMaster GRADE Centre
McMaster University
Hamilton, Ontario, Canada

Andrea Darzi, MD, MPH, PhD Candidate

Andrea Darzi, MD, MPH, PhD Candidate
Project Coordinator, Cochrane Canada
Department of Health Research Methods, Evidence,   and Impact
McMaster University
Hamilton, Ontario, Canada

Selection of a Risk Assessment Model for VTE Prevention in Hospitalized Medical Patientsexternal icon

Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, has an annual incidence in adult populations of approximately 1 per 1,000, and is a major burden in hospitalized medical patients. The risk of hospital-acquired VTE is reduced by using pharmacological and non-pharmacological interventions, but these interventions are not without potential patient harms.

Risk assessment models (RAMs) have been developed and employed to stratify hospitalized medically ill patients according to their risk of having VTE or a clinically significant bleeding event. Stratum-specific strategies optimizing patient management to prevent both VTE and bleeding events are recommended. RAMs are developed using data registries but ideally should also be informed by a systematic synthesis of all current evidence of potential risk factors.

In this webinar, Drs. Schünemann and Darzi will present the process and findings of a systematic review and a novel approach they conducted to identify risk factors for VTE and bleeding in hospitalized medical patients and develop RAMs. They will also highlight how these findings inform patient management, the validation of RAMs for hospitalized medical patients, and future guideline recommendations.

Photo of Steven Pipe, MD.

February 13, 2020

Steven Pipe, MD
Chair, Medical and Scientific Advisory Council, National Hemophilia Foundation
Director, Division of Pediatric Hematology and Oncology
Pediatric Medical Director, Hemophilia and Coagulation Disorders Program
Director, Special Coagulation Laboratory, University of Michigan

Photo of Dr. Margaret Ragni, MD MPH

Margaret Ragni, MD, MPH
Professor of Medicine, University of Pittsburgh Department of Medicine, Division of Hematology/Oncology
Professor of Clinical Translational Science at the Clinical Translational Science Institute University of Pittsburgh
Director, Hemophilia Center of Western Pennsylvania

Science Update: Inhibitor State of the Science Meetingexternal icon

Inhibitor formation is a serious complication of hemophilia treatment that occurs in 30% of patients at highest risk – youth with severe hemophilia A.  To develop a road map for needed research in this area, working groups met in 2019 at a State of the Science Symposium at the National Heart, Lung, and Blood Institute.

In this webinar, Drs. Pipe and Ragni discuss the progress and challenges in the design and implementation of research studies to prevent and eradicate inhibitors.

View the presentation slidespdf iconexternal icon

Archives for 2019

Alok Khorana

November 13, 2019

Alok A. Khorana, MD, FACP, FASCO
Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Services of the Taussig Cancer Institute (part of Case Comprehensive Cancer Center)
Director of the Gastrointestinal Malignancies Program at the Cleveland Clinic, Cleveland, Ohio

Prediction, Prevention, and Treatment of Cancer-associated Thrombosisexternal icon

In this webinar, Dr. Khorana will discuss the current risk assessment tools used to identify patients at high risk for cancer-associated VTE. He will also discuss emerging data on biomarkers, review the latest data and guidelines on prevention of VTE in cancer, and present best approaches to treatment of VTE in patients with active malignancy.

Jeffrey Weitz, MD

October 10, 2019

Jeffrey Weitz, MD
Professor of Medicine and Biochemistry and Biomedical Sciences, McMaster University
Executive Director of Thrombosis and Atherosclerosis Research Institute

Top 3 Considerations for the Prevention of Hospital-Associated Venous Thromboembolism (World Thrombosis Day webinar 2019)external icon

In this webinar co-hosted by CDC and the International Society on Thrombosis and Hemostasis, Dr. Weitz discusses the key considerations that healthcare providers and patients need to know to prevent hospital-associated venous thromboembolism.

Ashutosh Lal

August 13, 2019

Ashutosh Lal, MD
Professor of Pediatrics
UCSF School of Medicine
Director, Comprehensive Thalassemia Program
Co-Director, Bio-Iron Program
UCSF Benioff Children’s Hospital Oakland

Elliott Vichinsky

Elliott Vichinsky, MD
Professor of Pediatrics
UCSF School of Medicine
Director, Northern California Comprehensive Thalassemia Program
Medical Director, Hematology/Oncology
UCSF Benioff Children’s Hospital Oakland

2019 Scientific Update: Transfusion Guidelines for Thalassemia

The introduction of effective red blood cell (RBC) transfusions 50 years ago was a critical step in transforming thalassemia from a severe, fatal anemia into a chronic condition. In this webinar, Dr. Vichinsky and Dr. Lal review the range of complications associated with RBC transfusions in thalassemia. They also describe the guidelines for transfusion therapy in beta thalassemia major, the most common form of transfusion-dependent thalassemia. The webinar will also address transfusions in alpha thalassemia major, and recommendations for non-transfusion-dependent thalassemia.

Guy Young, MD

June 6, 2019

Guy Young, MD
Director, Hemostasis and Thrombosis, Center at Children’s Hospital Los Angeles
Associate Professor of Pediatrics, University of Southern California Keck School of Medicine

New Opportunities and Challenges in Hemophilia Treatment: 2019 Update

In this webinar, Dr. Young provides an overview to new and upcoming treatments for hemophilia. He also briefly review the data from published gene therapy trials. He will also discuss some of the unique challenges that new treatments raise for clinicians and provide some potential solutions to those challenges.

Neil Goldenberg MD, PhD

March 7, 2019

Neil A. Goldenberg, MD, PhD
Professor of Pediatrics and Medicine, Johns Hopkins University School of Medicine
Director, Johns Hopkins Medicine Pediatric Thrombosis Program, St. Petersburg, FL and Baltimore, MD
Director of Research, Johns Hopkins All Children’s Hospital and Chief Research Officer, All Children’s Research Institute, St. Petersburg, FL

Venous Thromboembolism in Children: 2019 Scientific Updateexternal icon

In this webinar, Dr. Goldenberg will discuss the key aspects of VTE in children, including risk factors, diagnosis, treatment, outcomes, prognostic factors, and prevention.  He will also review the recently released guidelines on the treatment of pediatric venous thromboembolism, published by the American Society of Hematology.

Janet L. Kwiatkowski, MD, MSCE

February 28, 2019

Janet L. Kwiatkowski, MD, MSCE
Director, Thalassemia Center of Children’s Hospital of Philadelphia
Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania

Thalassemia Management: Balancing Blood and Ironexternal icon

In this webinar, Dr. Kwiatkowski provides an overview of current, recommended treatments for people with thalassemia, with an emphasis on transfusion-dependent thalassemia.  She discusses best practices in transfusion, as well as monitoring and treatment of iron overload.

For more information on the webinar series, please contact Cindy Sayers at